You just read:

Lipocine Late-Breaker Presentation at EASL Meeting to Detail LPCN 1144 MRI-PDFF Based Clinical Results on Reduction of Liver Fat and Key Serum Biomarkers

News provided by

Lipocine Inc.

Mar 26, 2019, 08:00 ET